Last reviewed · How we verify
BGM-2121
At a glance
| Generic name | BGM-2121 |
|---|---|
| Sponsor | BioGate Precision Medicine Corp. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BGM-2121 CI brief — competitive landscape report
- BGM-2121 updates RSS · CI watch RSS
- BioGate Precision Medicine Corp. portfolio CI